title: Author's response on Arria (2016): Intention matters--using the terminology 'pharmacological neuroenhancement' as a behavioural definition based on the assumed functionality.
authors.affiliation: Swiss Research Institute for Public Health and Addiction (ISGF), Associated Institute at the University of Zurich and WHO Collaborating Centre, Zurich, Switzerland.
authors.forename: Larissa J
authors.initials: LJ
authors.lastname: Maier
authors.affiliation: Swiss Research Institute for Public Health and Addiction (ISGF), Associated Institute at the University of Zurich and WHO Collaborating Centre, Zurich, Switzerland.
authors.forename: Severin
authors.initials: S
authors.lastname: Haug
authors.affiliation: Swiss Research Institute for Public Health and Addiction (ISGF), Associated Institute at the University of Zurich and WHO Collaborating Centre, Zurich, Switzerland.
authors.forename: Michael P
authors.initials: MP
authors.lastname: Schaub
mesh_terms: D003071:Cognition; D006801:Humans; D033182:Intention; D009626:Terminology as Topic
keywords: Cognitive performance; mood; pharmacological neuroenhancement